Introduction
The specific inhibition of cytokines is frequently desired in brasiliensis (6, 7) . Treatment of mice with soluble IL-4Rα (3, 8) or inhibitory antibodies (2, 8) has similar effects and human experimental set-ups and is also part of many concepts for IL-4 antagonists have been applied to inhibit IgE production innovative clinical applications. Various strategies have been in humanized SCID mice (9) . Specific IL-4 inhibitors may described to block cytokine actions. Cyclosporin A and FK506 be useful for the therapy of diseases which involve T h 2 are prominent examples of reagents which interfere with development or IgE production. signal transduction pathways and inhibit the transcription of Antagonistic IL-4 mutants have been described by Kruse cytokine genes, most importantly, the IL-2 gene (1). However, et al. (10) . Three amino acids close to the C-terminus of IL-4 while these reagents are efficient immunosuppressive drugs, are important for association of γ c : Arg121, Tyr124 and Ser125 they lack specificity for a particular cytokine. Selective inhibi-(11). The substitution of other residues in these positions, tion has been achieved using antibodies directed against in particular the introduction of Asp, blocks the receptor cytokines or their receptors, or with soluble extracellular dimerization which mediates transmembrane signaling. receptor domains (2, 3) . Structural understanding of ligandMutations in Tyr124 are most effective, while changes in the receptor interactions has led to the development of cytokine other two residues lead to variants with considerable residual mutants with antagonistic properties, which fail to induce activity. These three amino acids comprise site II of the IL-4 receptor dimerization or oligomerization (see review in 4). The molecule (10, 11) . Site I, the region binding to IL-4Rα, is characterization of these cytokine antagonists may facilitate centered around Glu9 and Arg88 (11). IL-4 binds via site I the creation of small mimetics, which would be the preferred with a k d of 150 pM to IL-4Rα and this high affinity is conserved reagents for clinical applications.
in site II variants. IL-4 antagonists inhibit IL-13 as well (12), IL-4 is the only cytokine known to direct the differentiation because IL-13 requires IL-4Rα for signal transduction (13,14 (19) (20) (21) (22) . It was also demonstrated that B cells from annealing 56°C, 45 s; primer extension 72°C, 120 s). Amplification products were electrophoresed through agarose gels X-SCID patients lacking a functional γ c chain retain reactions towards . This evidence has led to the conclusion, and visualized by ethidium bromide staining. that IL-4 can use an alternative receptor subunit, probably a Proliferation assay component of the IL-13 receptor complex (24) .
We Cells were stimulated for 10 min with cytokines at 37°C and The pre-monocytic cell line THP-1 (ATTC TIB-202), the renal 5% CO 2 , pelleted, and suspended in ice-cold lysis buffer as carcinoma line Caki-1 (ATCC HTB-46) and a primary renal described, but with 1% NP-40 instead of Triton X-100 (14). carcinoma line established by Dr S. Krä mer and Dr D.
After spin-over rotation (30 min) the cell lysates were centriSchendel (Munich, Germany) were cultured in RPMI 1640 fuged at 10,000 g for 10 min. Cleared supernatants were plus 10% FCS, 100 units/ml penicillin and 100 µg/ml streptoincubated for 3 h at 4°C with antibody and the immune mycin at 37°C in a humidified atmosphere containing 5% complexes were collected on Protein A-Sepharose (Sigma, CO 2 . Peripheral human T cells were purified and cultured as Deisenhofen, Germany) for 1 h. Precipitates were washed described (25) .
twice with lysis buffer, twice with salt buffer (0.5 M LiCl in Human IL-2, IL-4, IL-4 variants and IL-7 were expressed in 100 mM Tris-HCl, pH 8.0) and boiled for 2 min in SDS sample Escherichia coli and purified as described (26, 27) . Human buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 26 mM dithiothreitol, IL-9 was a gift from Dr J.-C. Renauld (Leuwen, Belgium) and 10% glycerol). The samples were subjected to SDS-PAGE human IL-13 was a gift from Dr N. Vita (Sanofi, Labé ge, on 7.5% gels followed by Western blot analysis with RC20 or France).
anti-Stat6 antibody using an enhanced chemiluminescence For immunoprecipitation, mAb X14/38 against IL-4Rα (13), detection system (32). a rabbit serum against Stat6 (S-20; Santa Cruz, Heidelberg, Germany) and mAb 3VD4 against human IL-4 (28) were
Reporter gene construction and assays employed. Horseradish peroxidase-coupled RC20 (Affinity,
The vector pTKluc, a generous gift of Dr J. Altschmied, Nottingham, UK) was used for detection of phosphotyrosine Wü rzburg, was obtained by replacing the CAT gene in on Western blots. pBLCAT5 (33) by the luciferase structural gene from pXP2 (34) . Anti-human γ c antibodies used were TUGh4 (29) ,
The promoter/enhancer construct pE4TKluc was obtained by generously provided by Dr K. Sugamura (Sendai, Japan), cloning a ScaI-XhoI fragment of the reporter plasmid E4 (35) rabbit antiserum against the N-terminus of γ c (N-20) from containing a triplicate GAS sequence from the Iε promoter Santa Cruz and a rabbit antiserum raised against a peptide between the ScaI-XhoI sites of pTKluc. Plasmids were anacorresponding to the eight C-terminal amino acids of human lyzed by digestion with restriction endonucleases and DNA γ c as described by Russell et al. (30) .
sequencing, and were purified for transfection by cesium RT-PCR chloride density gradients.
Total RNA was isolated by the guanidinium thiocyanateTransient transfection, stimulation and Luc assays phenol-chloroform method (31) and quantitated by absorbance at 260 nm. PCR reactions were performed after reverse For electroporation, 7ϫ10 6 THP-1 cells in 350 µl complete medium supplemented with 5% FCS were mixed with 30 µg transcription of 1 µg total RNA using specific primers. The γ c primers (GenBank accession no. D11086) used were as supercoiled plasmid DNA (in 50 µl TE, pH 7.5). The transfection was performed by a single pulse (250 V, 1050 µF, 34-follows: 5Ј-TGGAGCACTTGGTGCAGTACCGGA-3Ј (562-585, sense) and 5Ј-CTGACGAGGCAGAGTCGTTCACTGT-3Ј 37 ms) from an Eurogentec Easyject Pulser. Subsequently, the cells were incubated in six-well tissue culture plates in (1012-988, antisense), yielding an amplification product of 450 bp. For controls, β-actin (GenBank accession nos X00351, complete medium with cytokines (100 ng/ml) for 24 h. Cell extracts were prepared by a freeze-thaw procedure. Protein J00074 and M10278) was used with the following primers: 5Ј-GACGGCCAGGTCATCACCATTGGCA-3Ј (771-795, sense) was determined according to Bradford (36) and Luc activities were measured with the Luciferase Assay System from and 5Ј-CCTAGAAGCATTTGCGGTGGACGAT-3Ј (1170-1146, Promega in a Lumat LB9581 luminometer (Berthold, Wildbad, Germany).
Radiolabeling and cross-linking ation was used as a sensitive assay of protein expression in Caki-1 cells. IL-4Rα was readily detectable in form of a IL-4 was iodinated by the Iodogen method (37) to a sp. act. of 3-8ϫ10 5 c.p.m./pmol as determined by binding assays, covalently linked complex with IL-4, but three types of antibodies against γ c failed to precipitate a complex of IL-4 with where competition between radiolabeled and unlabeled IL-4 for binding to the extracellular domain of IL-4Rα is measured γ c (Fig. 2) . Interestingly, antibodies against IL-4 or IL-4Rα coprecipitated bands of different mol. wt (94-105 kDa for anti-(11). Cross-linking with bis(sulfosuccinimidyl)suberate (Pierce, Rockford, IL) was performed as described (38) .
IL-4Rα and 82-90 and 68 kDa for anti-IL-4), which may represent either truncated forms of IL-4Rα or other subunits Briefly, 3ϫ10 7 cells were suspended in 0.5 ml RPMI plus 2% BSA and incubated with 1 nM iodinated IL-4 for 1 h at 4°C.
of the IL-4 receptor complex.
Caki-1 cells were tested for growth suppression by various After washing twice with RPMI, cross-linker was added to a concentration of 1 mM and 10 min later the same amount of cytokines (Fig. 3A) . IL-4 and IL-13 were equally efficient, decreasing the factor-independent proliferation by~40-50%. cross-linker was added for further 20 min. The cells were lysed and cleared supernatants were immunoprecipitated for A total of 37 IL-4 variants, mutated in 32 different amino acid residues, were tested for their efficiency in suppressing 4 h in the cold. For X14/38 and 3VD4, 5 µg antibody was added together with Protein G-Sepharose (Pharmacia proliferation of Caki-1 cells (Fig. 3B) . A particular aim of this experiment was to test whether antagonistic mutants could Biotech, Freiburg, Germany); for TUGh4, 0.25 µl of ascites was added with [goat-(anti-rat) IgG] agarose (Sigma) and for be identified outside of the previously recognized binding site near the C-terminus of IL-4. A few of the mutants used the two polyclonal antisera, Protein A-Sepharose was used to collect the immune complexes. Pellets were washed twice are located in the region contacting IL-4Rα, but the majority was selected to surround the site II in helix D, which is with ice cold lysis buffer and boiled for 2 min in SDS sample buffer. The precipitates were analyzed by SDS-PAGE on 7.5% involved in γ c association. The biological activity of site I mutants was impaired as expected, most noticeable of the gels, which were dried and visualized with a PhosphorImager system (Molecular Dynamics, Sunnyvale, CA). Molecular mutants E9K and R88D, for which it is known that their binding affinity to IL-4Rα is several thousand-fold lower compared to mass was determined using 14 C-labeled standards (Amersham Buchler, Braunschweig, Germany).
wild-type IL-4 (11). Outside of site I, R121D and Y124D were the only single-replacement mutants which had lost the ability to suppress proliferation of Caki-1 (Fig. 3B) . Double mutants Results involving these two amino acids were equally impaired. Mutations in the adjacent amino acid residues Lys117, Met120 Cell lines established from renal tumors lack γ c expression, but their autonomous proliferation is reduced in presence of and Ser125 had a much smaller effect, and all other mutations in that area of the IL-4 molecule did not interfere with biological IL-4 (39,40). Similarly, the pre-monocytic cell line THP-1 does not express γ c , but the transcription factor Stat6 is activated activity. To verify these findings, a second RCC-derived cell line was tested with a similar set of mutants. The results were by IL-4 treatment (19, 29, 41, 42) . We have used these two assay systems for the analysis of human IL-4 variants. First, identical to those obtained with Caki-1 cells (not shown). The EC 50 of IL-4-mediated growth suppression was 4 pM, RT-PCR was employed to confirm the γ c -negative status of the cells. Transcripts for γ c were found in peripheral blood which makes this response a high-affinity reaction (Fig. 3C) . In contrast, mutants R121D, Y124D and the double mutant lymphocytes, but not in THP-1 cells or in two different RCC lines (Fig. 1) .
R121D/Y124D failed to affect Caki-1 proliferation even at concentrations of Ͼ10 nM. On the other hand, all three Radioactive cross-linking combined with immunoprecipit-mutants were able to abolish the effects of IL-4 on Caki-1 mismatch (43). If another receptor protein assumes the role cells. A 25-fold excess of mutants versus wild-type was of γ c , it may contact a different region of IL-4 and mutations sufficient for a substantial level of inhibition (Fig. 3D) .
in site II could have entirely different effects. IL-4 and IL-13 stimulate tyrosine phosphorylation of the We have tested a wide range of IL-4 mutants to map the transcription factor Stat6 in Caki-1 (Fig. 4A) and THP-1 cells influence of amino acid replacements on signaling through (not shown), a response that is completely inhibited for both the type 2 IL-4 receptor complex. Two RCC cells lines and cytokines by R121D/Y124D. A set of mutants covering all the pre-monocytic line THP-1 were used for these experiexposed amino acid residues from the D-helix was tested for ments, after RT-PCR failed to detect transcripts for γ c in these this reaction on THP-1 cells (Fig. 4B) . Mutants R121D and cells. Cross-linking of radiolabeled ligand combined with Y124D did not stimulate phosphorylation over background immunoprecipitation was used to test for expression of receplevel, while mutants K117D, M120D and S125D appeared to tor subunits in Caki-1 cells. Complexes of IL-4 with IL-4Rα be impaired. All other mutants were as efficient as wild-type were easily detectable, but no complexes containing γ c protein. IL-4-induced Stat6 phosphorylation was also tested were found. Antibodies against IL-4 and against IL-4Rα coin phytohemagglutinin-prestimulated peripheral lymphocytes precipitated different smaller bands, which could be either (Fig. 4C) . In contrast to THP-1 cells, lymphocytes showed for degradation products of IL-4Rα or distinct proteins. The R121D and S125D a diminished, but clearly detectable Stat6 second subunit of the type 2 IL-4 receptor has a mol. wt of phosphorylation. Mutants Y124D and R121D/Y124D were 55-70 kDa according to cross-linking experiments (39,44). It inactive.
appears likely that it is identical to one of the two IL-13 binding Activated Stat6 induces gene transcription by binding to a proteins which have been cloned recently from human cells, subset of GAS elements. We have used a reporter gene assay which both have molecular weights in the same range (24, 45) . to quantitate effects of IL-4 mutants on the activation of GAS Either type of IL-13 receptor protein may be represented by elements. Three Stat6-specific GAS sites derived from the one of the bands seen in Fig. 2(lanes 4 and 5) . It is not clear human Iε regulatory region were coupled to a minimal prowhy antibodies against IL-4 precipitate a smaller band than moter and a reporter gene. IL-4 and IL-13 enhanced transcripantibodies against IL-4Rα. The anti-IL-4 antibody used, 3VD4, tion of the reporter gene in THP-1 cells~4-fold compared to binds to an epitope which includes residues Glu114 and unstimulated cells (Fig. 5) . Mutants R121D, Y124D and R121D/ Arg121 (28), so selective accessibility of the antigen after Y124D failed to stimulate transcription over background level, cross-linking of receptor proteins may be involved. while S125D appeared to be minimally impaired.
It is desirable to have a single inhibitor for all kinds of receptor complexes containing IL-4Rα, but selective inhibition Discussion of particular receptor subtypes would also be useful, e.g. as a convenient assay for receptor subtype usage on different IL-4 antagonists are useful to inhibit IL-4-and IL-13-dependent cells or for selective inhibition of cell types in vivo. reactions. Class switching to IgE, an antibody produced Replacement of some amino acids close to Arg121 and mainly in type I allergies and during infection with helminthic Tyr124 in the three-dimensional structure of the IL-4 molecule macroparasites, requires either IL-4 or IL-13, while the yielded small losses of biologic activity. This was observed development of a T h 2 phenotype is strictly dependent on IL-4.
for Lys117, Met120 and Ser125. These effects are similar to A T h 2 pattern of cytokine production leads in many cases to those found with type 1 receptor using cells, except for a exacerbation rather than a healing of diseases; so the Ser125 mutants, which are highly impaired for interacting with inhibition of IL-4 may be beneficial in other syndromes besides type 1 receptors (11,13). Mutation of Tyr124 to Asp prevented allergies (5) .
biological activity regardless of γ c usage. Both Y124D and The discovery of a second type of IL-4 receptor has raised R121D/Y124D can therefore be used as antagonists without the question, whether IL-4 antagonists like Y124D and R121D/ consideration of receptor composition. Y124D, well characterized in lymphocytes, are able to inhibit
The search for subtype-specific inhibitors yielded less these alternative type 2 receptors. Antagonistic IL-4 variants satisfying results. Despite extensive screening of mutants, inhibit the type 1 IL-4 receptor, because γ c is unable to no previously unrecognized sites with good antagonistic associate with complexes of IL-4Rα and mutant IL-4 (4,10).
properties were identified. Exchange of Arg121 or Tyr124 Receptor dimerization is prevented and no intracellular signals against Asp prevented biological activity of the mutant protein, are generated. These properties of site II mutants can be but residues surrounding this site according to structural explained by the loss of a hydrophobic area on the IL-4 molecule combined with the introduction of an electrostatic analysis were not essential for receptor activation. However, two main differences between type 1 and type 2 IL-4 receptor complexes were observed.
(i) The variant R121D, which has moderate antagonistic properties in type 1 receptor bearing cells, was completely unable to mediate growth suppression in RCC cell lines or stimulate Stat6 phosphorylation in THP-1 cells. Variant R121D was not only inactive by itself, but was a complete antagonistic for these cells as well.
(ii) The variant S125D, which is comparable in antagonistic properties to R121D in cells with type 1 receptors, was very similar to wild-type IL-4 for effects mediated through type 2 receptors. The activity of S125D was too close to the wildtype to determine any antagonistic properties.
We conclude that the recruitment of either γ c or its alternative subunit requires a small region in the D-helix of the IL-4 molecule. The contact site for the type 2 receptor seems to be shifted by one turn of the α-helix, so Arg121 is more important for type 2 compared to type 1 receptors, while Ser125 is not critical in forming type 2 receptor complexes. Residue R121 is also important for the interaction between human IL-4 and mouse γ c , which suggests that site II has some inherent flexibility in contacting different receptor proteins (46). The same study found for TF-1 cells, a human erythroleukemia line, an activity of S125D which was intermediate between R121D and wild-type. The expression level of γ c in TF-1 cells agonistic activity has ever been found for this variant.
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